Facial Wrinkles
1
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
SanofiNADGL
Apyx MedicalJ-Plasma
SanofiHylaform, Hylaform Plus
Clinical Trials (3)
Total enrollment: 45 patients across 3 trials
A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)
Start: Jan 2007Est. completion: Feb 200745 patients
Phase 3Completed
The Use of J-Plasma® for Dermal Resurfacing
Start: Jan 2018Est. completion: Nov 2018
N/ACompleted
A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast.
Start: Jun 2002Est. completion: Aug 2003
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space